About The Hamner
Create an open, multidisciplinary campus that acts as a catalyst with global academic institutions, industries, and government agencies to support innovative translational research and rapid technology development.
“The Hamner Institutes has a great heritage in studying the safety of small-molecule chemicals. It has also positioned itself with cutting-edge research at the key juncture in pharmaceutical development between basic research discovery and clinical studies.”
Charles E. Hamner, Jr., D.V.M., Ph.D.
Chairman, The Hamner Board of Directors
Message from the Chair
“The Hamner’s integrative platform, which includes academe, industry, and the government, will help advance public health policy decision-making and foster the translation of biomedical discoveries being made in North Carolina’s research laboratories into new medicines and diagnostics. ”
William F. Greenlee, Ph.D.
President and Chief Executive Officer